Galmed Pharmaceuticals Ltd. (GLMD)
USD 2.9
(-3.65%)
USD 2.9
(-3.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.13 Million | -18.5 Million | -32.89 Million | -26.28 Million | -14.93 Million | -9.02 Million |
| Net Income | -6.91 Million | -17.86 Million | -32.46 Million | -28.77 Million | -20.46 Million | -9.85 Million |
| Depreciation & Amortization | 31 Thousand | 35 Thousand | 42 Thousand | 39 Thousand | 35 Thousand | 387 Thousand |
| Deferred income taxes | -1.29 Million | - | 84 Thousand | -437 Thousand | -114 Thousand | 12 Thousand |
| Stock-based compensation | 892 Thousand | 1.29 Million | 1.88 Million | 2.06 Million | 2.23 Million | 1.78 Million |
| Change in working capital | 132 Thousand | -2.45 Million | -2.45 Million | 1.1 Million | 3.43 Million | -1.2 Million |
| Other non-cash items | 1.01 Million | 485 Thousand | 13 Thousand | -285 Thousand | -63 Thousand | -144 Thousand |
| Investing Cash Flow | 800 Thousand | 17.56 Million | 11.46 Million | 16.53 Million | 6.67 Million | -60.01 Million |
| Investments in PPE | - | -4000.00 | -11 Thousand | -44 Thousand | -12 Thousand | -90 Thousand |
| Acquisitions | -1.5 Million | -17.56 Thousand | - | -24.94 Million | 21.79 Million | 6.07 Million |
| Investment purchases | -7.83 Million | -3.87 Million | -13.56 Million | -55.03 Million | -94.4 Million | -98.34 Million |
| Sales/Maturities of investments | 8.63 Million | 21.44 Million | 25.04 Million | 71.61 Million | 101.09 Million | 38.42 Million |
| Other Investing Activities | 1.5 Million | 17.56 Thousand | -1000.00 | 24.94 Million | -21.79 Million | -6.07 Million |
| Financing Cash Flow | 6.18 Million | 70 Thousand | 17.36 Million | 768 Thousand | 143 Thousand | 80.17 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.18 Million | 70 Thousand | 17.36 Million | 707 Thousand | 143 Thousand | 80.17 Million |
| Other Financing Activities | 6185.00 | 70.00 | 17.36 Thousand | 61 Thousand | 143.00 | 80.17 Million |
| Accounts receivables | 345 Thousand | 300 Thousand | -313 Thousand | 15 Thousand | -609 Thousand | -63 Thousand |
| Accounts payables | -681 Thousand | -2.31 Million | -2.17 Million | 1.04 Million | 4.18 Million | -462 Thousand |
| Inventory | - | -300 Thousand | 313 Thousand | -15 Thousand | 609 Thousand | -142 Thousand |
| Other working capital | 468 Thousand | -140 Thousand | -275 Thousand | 54 Thousand | -750 Thousand | -538 Thousand |
| Cash at beginning of period | 2.13 Million | 2.99 Million | 7.06 Million | 16.04 Million | 24.15 Million | 13.02 Million |
| Cash at end of period | 2.97 Million | 2.13 Million | 2.99 Million | 7.06 Million | 16.04 Million | 24.15 Million |
| Capital Expenditure | - | -4000.00 | -11 Thousand | -44 Thousand | -12 Thousand | -90 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 848 Thousand | -868 Thousand | -4.06 Million | -8.98 Million | -8.11 Million | 11.13 Million |
| Free Cash Flow | -6.13 Million | -18.5 Million | -32.9 Million | -26.33 Million | -14.94 Million | -9.11 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.11 Million | -1.27 Million | -6.91 Million | -2.01 Million | -1.47 Million | -1.59 Million |
| Depreciation & Amortization | 74 Thousand | 9000.00 | 31 Thousand | 6000.00 | 8000.00 | 9000.00 |
| Deferred income taxes | - | - | -1.29 Million | 488 Thousand | 86 Thousand | -317 Thousand |
| Stock-based compensation | 130 Thousand | 153 Thousand | 892 Thousand | 195 Thousand | 226 Thousand | 174 Thousand |
| Change in working capital | -92 Thousand | -718 Thousand | 132 Thousand | 993 Thousand | -1.02 Million | 202 Thousand |
| Other non-cash items | 329 Thousand | 442 Thousand | 1.01 Million | -564 Thousand | 3000.00 | 158 Thousand |
| Investing Cash Flow | 1.39 Million | 432 Thousand | 800 Thousand | 2.27 Million | -3.53 Million | 705 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | -1.5 Million | - | - | - |
| Investment purchases | -234 Thousand | -1.27 Million | -7.83 Million | -907 Thousand | -4.85 Million | -2.82 Million |
| Sales/Maturities of investments | 1.62 Million | 1.7 Million | 8.63 Million | -214 Thousand | 1.32 Million | 5.03 Million |
| Other Investing Activities | 1.39 Million | 432 Thousand | 1.5 Million | 3.4 Million | -3.4 Million | -1.5 Million |
| Financing Cash Flow | - | - | 6.18 Million | - | 6.18 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 6.18 Million | - | 6.18 Million | - |
| Other Financing Activities | - | - | 6185.00 | - | 6185.00 | - |
| Accounts receivables | 119 Thousand | 226 Thousand | 345 Thousand | 290 Thousand | -429 Thousand | 227 Thousand |
| Accounts payables | -180 Thousand | -496 Thousand | -681 Thousand | 405 Thousand | -666 Thousand | -126 Thousand |
| Inventory | - | - | - | - | 429 Thousand | -227 Thousand |
| Other working capital | -31 Thousand | -448 Thousand | 468 Thousand | 298 Thousand | -361 Thousand | 328 Thousand |
| Cash at beginning of period | 1.58 Million | 2.97 Million | 2.13 Million | 1.59 Million | 1.12 Million | 1.78 Million |
| Cash at end of period | 1.95 Million | 1.58 Million | 2.97 Million | 2.97 Million | 1.59 Million | 1.12 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 375 Thousand | -1.39 Million | 848 Thousand | 1.38 Million | 473 Thousand | -662 Thousand |
| Free Cash Flow | -1.01 Million | -1.83 Million | -6.13 Million | -898 Thousand | -2.17 Million | -1.36 Million |
SHJBF
019170
LSRCF
BAJEL
1317
NIITMTS